GSE126529 MYC inhibition B cell 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126529_MYC inhibition_B cell_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126529_MYC inhibition_B cell_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126529_MYC inhibition_B cell_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126529_MYC inhibition_B cell_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

WD repeat domain 46

Gene

zinc finger protein 839 pseudogene

Gene

SBDS pseudogene 1

Gene

small nucleolar RNA host gene 26

Gene

ring finger protein 216 pseudogene 1

Gene

GUSB pseudogene 1

Gene

long intergenic non-protein coding RNA 3009

Gene

lung cancer immune cell infiltration associated lncRNA

Gene

PINK1 antisense RNA

Gene

MT-CO3 pseudogene 29

  • Gene

    WD repeat domain 46


  • Gene

    zinc finger protein 839 pseudogene


  • Gene

    SBDS pseudogene 1


  • Gene

    small nucleolar RNA host gene 26


  • Gene

    ring finger protein 216 pseudogene 1


  • Gene

    GUSB pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 3009


  • Gene

    lung cancer immune cell infiltration associated lncRNA


  • Gene

    PINK1 antisense RNA


  • Gene

    MT-CO3 pseudogene 29

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.